These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11696457)

  • 1. Exposure of mice to topical bovine thrombin induces systemic autoimmunity.
    Schoenecker JG; Johnson RK; Lesher AP; Day JD; Love SD; Hoffman MR; Ortel TL; Parker W; Lawson JH
    Am J Pathol; 2001 Nov; 159(5):1957-69. PubMed ID: 11696457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical use and immunologic impact of thrombin in surgery.
    Lawson JH
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():98-110. PubMed ID: 16673271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
    Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
    Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent autoimmune response of dichloroacetyl chloride in female MRL +/+ mice.
    Khan MF; Kaphalia BS; Ansari GA
    Immunopharmacol Immunotoxicol; 1997 May; 19(2):265-77. PubMed ID: 9130009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
    Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
    J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk and clinical significance of developing antibodies induced by topical thrombin preparations.
    Dorion RP; Hamati HF; Landis B; Frey C; Heydt D; Carey D
    Arch Pathol Lab Med; 1998 Oct; 122(10):887-94. PubMed ID: 9786349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms.
    Hudson CA; Cao L; Kasten-Jolly J; Kirkwood JN; Lawrence DA
    J Toxicol Environ Health A; 2003 May; 66(10):895-918. PubMed ID: 12825236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of antibodies to the topical hemostat bovine thrombin.
    Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
    J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological consequences of topical bovine thrombin.
    Zehnder JL; Leung LL
    Am J Pathol; 2001 Dec; 159(6):2371. PubMed ID: 11733385
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiphospholipid antibodies after surgical exposure to topical bovine thrombin.
    Su Z; Izumi T; Thames EH; Lawson JH; Ortel TL
    J Lab Clin Med; 2002 Jun; 139(6):349-56. PubMed ID: 12066133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice.
    Wen ZK; Xu W; Xu L; Cao QH; Wang Y; Chu YW; Xiong SD
    Rheumatology (Oxford); 2007 Dec; 46(12):1796-803. PubMed ID: 18032537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory role of NZB T lymphocytes in the production of anti-DNA antibodies in vitro.
    Laskin CA; Haddad G; Soloninka CA
    J Immunol; 1986 Sep; 137(6):1867-73. PubMed ID: 3489043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice.
    Verthelyi D; Ansar Ahmed S
    J Autoimmun; 1997 Apr; 10(2):115-25. PubMed ID: 9185873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
    Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
    Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
    Ofosu FA; Crean S; Reynolds MW
    Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-DNA antibodies: structure, specificity, and biology.
    Marion TN; Krishnan MR; Desai DD; Jou NT; Tillman DM
    Methods; 1997 Jan; 11(1):3-11. PubMed ID: 8990083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
    Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
    Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-DNA knock-in model of systemic autoimmunity induced by the chronic graft-vs-host reaction.
    Eisenberg R; Choudhury A
    Methods Mol Med; 2004; 102():273-84. PubMed ID: 15286390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
    Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
    J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.